ImmuneOncia Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	645,978	965,629	-	-	-	-
Enterprise Value	622,610	934,053	-	-	-	-
Last Close Price	8710.00	13020.00	-	-	-	-
PS Ratio	5808.70	8683.03	-	-	-	-
PB Ratio	22.73	33.98	-	-	-	-
P/TBV Ratio	27.01	40.38	-	-	-	-
EV/Sales Ratio	-	8399.10	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.00	0.00
Net Debt / Equity Ratio	-0.82	-0.82	-0.58	-0.86	0.51	0.71
Net Debt / EBITDA Ratio	0.86	0.86	0.97	2.40	1.90	3.86
Net Debt / FCF Ratio	1.01	1.01	0.76	2.95	1.74	20.22
Asset Turnover	0.00	0.00	0.02	0.00	0.18	0.00
Quick Ratio	5.53	5.53	3.00	7.75	7.16	4.80
Current Ratio	6.22	6.22	3.06	7.90	7.53	4.84
Return on Equity (ROE)	-114.39%	-114.39%	-22.97%	-	-	-
Return on Assets (ROA)	-58.99%	-58.99%	-26.25%	-21.22%	-21.71%	-18.57%
Return on Capital Employed (ROCE)	-96.90%	-96.90%	-63.90%	-38.80%	-47.30%	-28.10%
Earnings Yield	-4.24%	-2.83%	-	-	-	-
FCF Yield	-3.58%	-2.39%	-	-	-	-
Buyback Yield / Dilution	-24.61%	-24.61%	-7.35%	-0.64%	-12.17%	-904.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.